This inventor holds 2 USPTO granted patents. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Ikuo Shinohara: Innovator in Pharmaceutical Chemistry
Introduction
Ikuo Shinohara is a notable inventor based in Tosu, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work at Hisamitsu Pharmaceutical Company, Inc. His expertise and creativity have led to the development of valuable compounds that have potential applications in medicine.
Latest Patents
Ikuo Shinohara holds 2 patents that showcase his inventive capabilities. His latest patents include a Diphenylthiazole derivative and Phenylalkanoic acid derivatives. The latter patent describes a novel phenylalkanoic acid derivative represented by a specific formula, where n is an integer of 1-2, X is a halogen atom, alkoxyl group, or nitro group, R is a hydrogen atom or alkyl group, and Z is a hydrogen atom or acyl group. These innovations reflect his commitment to advancing pharmaceutical research.
Career Highlights
Throughout his career, Ikuo Shinohara has been instrumental in developing new chemical compounds that can lead to improved therapeutic options. His work at Hisamitsu Pharmaceutical Company, Inc. has positioned him as a key figure in the pharmaceutical industry, contributing to the company's reputation for innovation and quality.
Collaborations
Ikuo has collaborated with talented individuals such as Masaru Saita and Hisataka Inoue. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the creative process in their research endeavors.
Conclusion
Ikuo Shinohara's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in the field, showcasing the importance of innovation in developing new medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile